Can patient ancestry influence molecular classifications in myeloid neoplasms?

Autor: Júnior HLR; Cancer Cytogenomic Laboratory, Center for Research and Drug Development (NPDM), Federal University of Ceara, Fortaleza, Ceara, Brazil.; Post-Graduate Program of Pathology, Federal University of Ceara, Fortaleza, Ceara, Brazil.; Post-Graduate Program of Translational Medicine, Federal University of Ceara, Fortaleza, Ceara, Brazil., Gusmão JNFM; Post-Graduate Program of Pathology, Federal University of Ceara, Fortaleza, Ceara, Brazil., Goes JVC; Cancer Cytogenomic Laboratory, Center for Research and Drug Development (NPDM), Federal University of Ceara, Fortaleza, Ceara, Brazil.; Post-Graduate Program of Pathology, Federal University of Ceara, Fortaleza, Ceara, Brazil.
Jazyk: angličtina
Zdroj: Histopathology [Histopathology] 2024 Nov 20. Date of Electronic Publication: 2024 Nov 20.
DOI: 10.1111/his.15375
Databáze: MEDLINE
Externí odkaz: